Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by cool888on Feb 15, 2021 10:03am
384 Views
Post# 32567745

$RVV $RVVTF - EUA vs. FDA Approval (From ragstorum reddit)

$RVV $RVVTF - EUA vs. FDA Approval (From ragstorum reddit)
EUA vs. FDA Approval (From ragstorum reddit)
There’s been some discussion regarding EUA vs. FDA Approval potentially coming out of Revive’s phase 3 clinical trial for bucillamine. EUA is on the table first. Revive has a VERY EXCELLENT shot here.
The FDA has a lot of flexibility on how to extend that authorization. This info from Duke Health gets into EUA vs FDA Approval:
Emergency Use Authorization – the known and potential benefits outweigh the known and potential risks, including manufacturing purity and reliability.
Emergency use may be authorized for specific populations —such as those at higher risk including healthcare workers—or potentially for a broader population.
EUA offers FDA flexibility regarding approval standards:
(e.g.) For convalescent plasma, FDA authorized emergency use based largely on observational data analysis, and could be augmented/refined through additional observational analysis
(e.g.) For COVID-19 vaccines, FDA plans to issue an EUA only once clinical studies have

<< Previous
Bullboard Posts
Next >>